サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1605879

DNA診断市場、規模、シェア、動向、産業分析レポート：提供別、技術別、検体別、用途別、エンドユーザー別、地域別 - 市場予測 2025年～2034年

DNA Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Offering, Technology, Specimen, Application, End User, and Region - Market Forecast, 2025 - 2034

出版日
ページ情報
英文 120 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
DNA診断市場、規模、シェア、動向、産業分析レポート：提供別、技術別、検体別、用途別、エンドユーザー別、地域別 - 市場予測 2025年～2034年
出版日: 2024年11月01日
発行: Polaris Market Research
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のDNA診断市場規模は2034年までに313億1,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

DNA診断市場の拡大は、世界の遺伝性疾患の有病率の上昇が原動力となっています。世界保健機関（WHO）は、単一の遺伝子の変異によって引き起こされる単発性疾患は約10,000種類あると推定しています。世界の有病率は1,000人あたり約10人で、7,000万人から8,000万人が遺伝性疾患に罹患していることになります。このような遺伝子疾患の急増により、遺伝子疾患を検出・評価するための効率的なツールに対する需要が高まっています。その結果、希少遺伝性疾患、遺伝性がん、遺伝性代謝異常の罹患率の増加が診断技術の進歩を促し、DNA診断市場を刺激しています。

DNA診断市場は、ゲノム技術の進歩により、遺伝子検査の精度、スピード、価格が向上し、大きな成長を遂げています。例えば、2024年5月、ゲノム研究・技術企業であるBioAro社は、ヒトゲノムの複雑性をリアルタイムで洞察するソフトウェアPanOmiQを発表しました。このような技術的強化により、詳細なゲノム解析が容易になり、より詳細で信頼性の高い診断結果が得られるようになります。このように、ゲノム技術の継続的な進化は、新しい診断ツールや診断方法の開発をサポートすることで、DNA診断市場の成長を促進しています。

ヘルスケア企業は、技術革新、研究、新しい診断技術の進歩を促進するために資金投資を拡大しています。このような投資は、ゲノム研究の進展、検査手法の改良、DNA診断の精度と信頼性の向上を後押ししています。その結果、企業の投資は研究機関との協力やヘルスケア診療への遺伝子検査の統合を加速させ、世界のDNA診断薬市場の拡大を促しています。

DNA診断市場レポートハイライト

試薬・キット分野は、遺伝子検査用に調整された包括的なスイートの市場発により、世界市場で大幅なCAGRの成長が見込まれます。

2023年には、がんの世界の有病率の増加により、がん遺伝子検査分野が最大の市場シェアを占めました。

2023年、北米は確立された機関や強固なヘルスケアインフラが存在するため、売上高で世界のDNA診断市場を独占しました。

中国のDNA診断市場は、バイオテクノロジーとヘルスケアインフラへの投資が増加していることから、大幅な成長が見込まれています。

世界の主要市場企業は、Abbott; Agilent Technologies, Inc.; Avalon GloboCare Corp.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Cepheid; F. Hoffmann-La Roche Ltd; GE HealthCare; Hologic, Inc.; Illumina, Inc.; QIAGEN; Siemens Healthcare Private Limited; and Thermo Fisher Scientific Inc.社です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のDNA診断市場の洞察

  • 市場スナップショット
  • DNA診断市場力学
    • 促進要因と機会
      • DNA診断サービスの拡大が市場の成長を牽引
      • ヘルスケア企業による投資が市場規模を押し上げている
    • 抑制要因と課題
      • 厳しい規制要件が市場拡大に影響を与える
  • PESTEL分析
  • DNA診断市場の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のDNA診断市場：提供別

  • 主な調査結果
  • イントロダクション
  • 機器
  • 試薬とキット
  • サービスとソフトウェア

第6章 世界のDNA診断市場：技術別

  • 主な調査結果
  • イントロダクション
  • インサイチューハイブリダイゼーション
  • 質量分析
  • マイクロアレイ
  • ポリメラーゼ連鎖反応（PCR）
  • シーケンシング
  • その他

第7章 世界のDNA診断市場：検体別

  • 主な調査結果
  • イントロダクション
  • 血液、血清、血漿
  • 尿
  • その他

第8章 世界のDNA診断市場：用途別

  • 主な調査結果
  • イントロダクション
  • がん遺伝子検査
  • 感染症DNA検査
  • 新生児遺伝子スクリーニング
  • 着床前診断と生殖診断
  • 非感染性疾患のDNA検査
  • 血液学および免疫学/身元診断および法医学
  • 薬理ゲノム学/薬物代謝
  • 出生前DNAキャリアスクリーニング
  • その他

第9章 世界のDNA診断市場：エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 診断検査室
  • 病院・診療所
  • その他

第10章 世界のDNA診断市場：地域別

  • 主な調査結果
  • イントロダクション
    • DNA診断市場評価：地域、2020-2034年
  • 北米
    • 北米：提供別、2020-2034年
    • 北米：技術別、2020-2034年
    • 北米：検体別、2020-2034年
    • 北米：用途別、2020-2034年
    • 北米：エンドユーザー別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：提供別、2020-2034年
    • 欧州：テクノロジー別、2020-2034年
    • 欧州：検体別、2020-2034年
    • 欧州：用途別、2020-2034年
    • 欧州：エンドユーザー別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：提供別、2020年～2034年
    • アジア太平洋：テクノロジー別、2020-2034年
    • アジア太平洋：検体別、2020-2034年
    • アジア太平洋：用途別、2020-2034年
    • アジア太平洋：エンドユーザー別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：提供別、2020～2034年
    • 中東・アフリカ：技術別、2020～2034年
    • 中東・アフリカ：検体別、2020-2034年
    • 中東・アフリカ：用途別、2020～2034年
    • 中東・アフリカ：エンドユーザー別、2020-2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：提供別、2020-2034年
    • ラテンアメリカ：技術別、2020-2034年
    • ラテンアメリカ：検体別、2020-2034年
    • ラテンアメリカ：用途別、2020-2034年
    • ラテンアメリカ：エンドユーザー別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第11章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第12章 企業プロファイル

  • Abbott
  • Agilent Technologies, Inc.
  • Avalon GloboCare Corp.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cepheidc
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare
  • Hologic, Inc.
  • Illumina, Inc.
  • Siemens Healthcare Private Limited
  • Thermo Fisher Scientific Inc.
図表

List of Tables:

  • Table 1 Global DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 2 Global DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 3 Global DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 4 Global DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 5 Global DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 6 North America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 7 North America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 8 North America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 9 North America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 10 North America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 11 U.S.: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 12 U.S.: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 13 U.S.: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 14 U.S.: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 15 U.S.: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 16 Canada: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 17 Canada: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 18 Canada: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 19 Canada: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 20 Canada: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 21 Europe: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 22 Europe: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 23 Europe: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 24 Europe: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 25 Europe: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 26 UK: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 27 UK: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 28 UK: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 29 UK: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 30 UK: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 31 France: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 32 France: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 33 France: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 34 France: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 35 France: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 36 Germany: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 37 Germany: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 38 Germany: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 39 Germany: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 40 Germany: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 41 Italy: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 42 Italy: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 43 Italy: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 44 Italy: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 45 Italy: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 46 Spain: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 47 Spain: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 48 Spain: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 49 Spain: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 50 Spain: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 51 Netherlands: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 52 Netherlands: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 53 Netherlands: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 54 Netherlands: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 55 Netherlands: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 56 Russia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 57 Russia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 58 Russia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 59 Russia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 60 Russia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 61 Rest of Europe: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 62 Rest of Europe: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 63 Rest of Europe: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 64 Rest of Europe: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 65 Rest of Europe: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 66 Asia Pacific: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 67 Asia Pacific: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 68 Asia Pacific: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 69 Asia Pacific: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 70 Asia Pacific: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 71 China: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 72 China: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 73 China: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 74 China: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 75 China: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 76 India: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 77 India: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 78 India: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 79 India: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 80 India: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 81 Malaysia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 82 Malaysia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 83 Malaysia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 84 Malaysia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 85 Malaysia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 86 Japan: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 87 Japan: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 88 Japan: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 89 Japan: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 90 Japan: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 91 Indonesia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 92 Indonesia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 93 Indonesia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 94 Indonesia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 95 Indonesia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 96 South Korea: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 97 South Korea: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 98 South Korea: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 99 South Korea: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 100 South Korea: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 101 Australia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 102 Australia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 103 Australia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 104 Australia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 105 Australia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 106 Rest of Asia Pacific: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 107 Rest of Asia Pacific: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 108 Rest of Asia Pacific: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 109 Rest of Asia Pacific: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 110 Rest of Asia Pacific: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 111 Middle East & Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 112 Middle East & Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 113 Middle East & Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 114 Middle East & Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 115 Middle East & Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 116 Saudi Arabia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 117 Saudi Arabia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 118 Saudi Arabia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 119 Saudi Arabia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 120 Saudi Arabia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 121 UAE: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 122 UAE: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 123 UAE: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 124 UAE: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 125 UAE: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 126 Israel: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 127 Israel: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 128 Israel: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 129 Israel: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 130 Israel: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 131 South Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 132 South Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 133 South Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 134 South Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 135 South Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 136 Rest of Middle East & Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 137 Rest of Middle East & Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 138 Rest of Middle East & Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 139 Rest of Middle East & Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 140 Rest of Middle East & Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 141 Latin America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 142 Latin America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 143 Latin America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 144 Latin America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 145 Latin America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 146 Mexico: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 147 Mexico: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 148 Mexico: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 149 Mexico: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 150 Mexico: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 151 Brazil: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 152 Brazil: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 153 Brazil: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 154 Brazil: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 155 Brazil: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 156 Argentina: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 157 Argentina: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 158 Argentina: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 159 Argentina: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 160 Argentina: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • Table 161 Rest of Latin America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • Table 162 Rest of Latin America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • Table 163 Rest of Latin America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • Table 164 Rest of Latin America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • Table 165 Rest of Latin America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • List of Figures:
  • Figure 1. Global DNA Diagnostics Market, 2020-2034 (USD billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Offering
  • Figure 7. Global DNA Diagnostics Market, by Offering, 2024 & 2034 (USD billion)
  • Figure 8. Market by Technology
  • Figure 9. Global DNA Diagnostics Market, by Technology, 2024 & 2034 (USD billion)
  • Figure 10. Market by Specimen
  • Figure 11. Global DNA Diagnostics Market, by Specimen, 2024 & 2034 (USD billion)
  • Figure 12. Market by Application
  • Figure 13. Global DNA Diagnostics Market, by Application, 2024 & 2034 (USD billion)
  • Figure 14. Market by End User
  • Figure 15. Global DNA Diagnostics Market, by End User, 2024 & 2034 (USD billion)

Figure 16. Global DNA Diagnostics Market Assessment, By Geography, 2020-2034 (USD billion)

  • Figure 17. Strategic Analysis - Global DNA Diagnostics Market
目次
Product Code: PM5229

The global DNA diagnostics market size is expected to reach USD 31.31 billion by 2034, according to a new study by Polaris Market Research. The report "DNA Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Offering (Instruments, Reagents & Kits, and Services & Software), Technology, Specimen, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025 - 2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The expansion of the DNA diagnostics market is being driven by the rising prevalence of genetic disorders worldwide. The World Health Organization (WHO) estimated that there are around 10,000 different types of monogenic diseases caused by mutations in a single gene. The global prevalence rate is approximately 10 per 1000 individuals, indicating that between 70 million and 80 million people are affected by genetic disorders. This surge in genetic conditions has created an increased demand for efficient tools to detect and evaluate genetic disorders. Consequently, the growing incidence of rare genetic diseases, hereditary cancers, and inherited metabolic disorders is propelling the advancement of diagnostic technologies, thereby stimulating the DNA diagnostics market.

The market for DNA diagnostics is experiencing significant growth due to the advancements in genomic technology, which have improved the accuracy, speed, and affordability of genetic testing. For instance, in May 2024, BioAro, a genomic research and technology company, launched PanOmiQ, a software that provides real-time insights into the complexities of the human genome. These types of technological enhancements facilitate in-depth genome analysis, resulting in more detailed and dependable diagnostic outcomes. Thus, the ongoing evolution of genomic technologies is driving the growth of the DNA diagnostics market by supporting the development of new diagnostic tools and methods.

Healthcare firms are escalating their financial investments to drive innovation, research, and the advancement of new diagnostic technologies. These investments are empowering companies to progress genomic research, refine testing methodologies, and enhance the precision and dependability of DNA diagnostics. Consequently, company investments are accelerating collaborations with research institutions and the integration of genetic testing into healthcare practices, thereby stimulating the expansion of the global DNA diagnostics market.

DNA Diagnostics Market Report Highlights

The reagents and kits segment is expected to grow with a substantial CAGR in the global market, driven by the development of comprehensive suites tailored for genetic testing.

In 2023, the cancer genetics tests segment accounted for the largest market share because of the increasing prevalence of cancer globally.

In 2023, North America dominated the global DNA diagnostics market in terms of revenue due to the presence of well-established institutions and a robust healthcare infrastructure in the region.

The DNA diagnostics market in China is expected to grow substantially because of the country's increasing investment in biotechnology and healthcare infrastructure.

The global key market players are Abbott; Agilent Technologies, Inc.; Avalon GloboCare Corp.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Cepheid; F. Hoffmann-La Roche Ltd; GE HealthCare; Hologic, Inc.; Illumina, Inc.; QIAGEN; Siemens Healthcare Private Limited; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the DNA diagnostics market report based on offering, technology, specimen, application, end user, and region:

By Offering Outlook (Revenue - USD Billion, 2019 - 2032)

  • Instruments
  • Reagents & Kits
  • Services & Software

By Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • In Situ Hybridization
  • Mass Spectroscopy
  • Microarrays
  • Polymerase Chain Reaction (PCR)
  • Sequencing
  • Others

By Specimen Outlook (Revenue - USD Billion, 2019 - 2032)

  • Blood, Serum, and Plasma
  • Urine
  • Others

By Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Cancer Genetics Tests
  • Infectious Diseases DNA Testing
  • CT/NG Diagnostic
  • HBV Diagnostic
  • HCV Diagnostic
  • HIV Diagnostic
  • HPV Diagnostic
  • MRSA Diagnostic
  • TB Diagnostic
  • Others
  • Newborn Genetic Screening
  • Preimplantation & Reproductive Diagnosis
  • Non-Infectious Diseases DNA Testing
  • Cardiovascular Diseases
  • CNS & PNS Related
  • Lung, Kidney, Liver & GT Related
  • Sensory Diseases
  • Skeletal, Connective, Ectodermal & Dermal DNA Testing
  • Hematology & Immunology/Identity Diagnostics & Forensics
  • Pharmacogenomics/Drug Metabolism
  • Prenatal DNA Carrier Screening
  • Others

By End User Outlook (Revenue - USD Billion, 2019 - 2032)

  • Diagnostic laboratories
  • Hospitals & clinics
  • Others

By Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global DNA Diagnostics Market Insights

  • 4.1. DNA Diagnostics Market - Market Snapshot
  • 4.2. DNA Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Expansion of DNA Testing Services Are Driving Market Growth
      • 4.2.1.2. Investments by Healthcare Companies Are Propelling Market Size
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent Regulatory Requirements Affects the Market Expansion
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. DNA Diagnostics Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global DNA Diagnostics Market, by Offering

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
  • 5.3. Instruments
    • 5.3.1. Global DNA Diagnostics Market, by Instruments, by Region, 2020-2034 (USD billion)
  • 5.4. Reagents & Kits
    • 5.4.1. Global DNA Diagnostics Market, by Reagents & Kits, by Region, 2020-2034 (USD billion)
  • 5.5. Services & Software
    • 5.5.1. Global DNA Diagnostics Market, by Services & Software, by Region, 2020-2034 (USD billion)

6. Global DNA Diagnostics Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
  • 6.3. In Situ Hybridization
    • 6.3.1. Global DNA Diagnostics Market, by In Situ Hybridization, by Region, 2020-2034 (USD billion)
  • 6.4. Mass Spectroscopy
    • 6.4.1. Global DNA Diagnostics Market, by Mass Spectroscopy, by Region, 2020-2034 (USD billion)
  • 6.5. Microarrays
    • 6.5.1. Global DNA Diagnostics Market, by Microarrays, by Region, 2020-2034 (USD billion)
  • 6.6. Polymerase Chain Reaction (PCR)
    • 6.6.1. Global DNA Diagnostics Market, by Polymerase Chain Reaction (PCR), by Region, 2020-2034 (USD billion)
  • 6.7. Sequencing
    • 6.7.1. Global DNA Diagnostics Market, by Sequencing, by Region, 2020-2034 (USD billion)
  • 6.8. Others
    • 6.8.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)

7. Global DNA Diagnostics Market, by Specimen

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
  • 7.3. Blood, Serum, and Plasma
    • 7.3.1. Global DNA Diagnostics Market, by Blood, Serum, and Plasma, by Region, 2020-2034 (USD billion)
  • 7.4. Urine
    • 7.4.1. Global DNA Diagnostics Market, by Urine, by Region, 2020-2034 (USD billion)
  • 7.5. Others
    • 7.5.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)

8. Global DNA Diagnostics Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
  • 8.3. Cancer Genetics Tests
    • 8.3.1. Global DNA Diagnostics Market, by Cancer Genetics Tests, by Region, 2020-2034 (USD billion)
  • 8.4. Infectious Diseases DNA Testing
    • 8.4.1. Global DNA Diagnostics Market, by Infectious Diseases DNA Testing, by Region, 2020-2034 (USD billion)
    • 8.4.2. CT/NG Diagnostic
      • 8.4.2.1. Global DNA Diagnostics Market, by CT/NG Diagnostic, by Region, 2020-2034 (USD billion)
    • 8.4.3. HBV Diagnostic
      • 8.4.3.1. Global DNA Diagnostics Market, by HBV Diagnostic, by Region, 2020-2034 (USD billion)
    • 8.4.4. HCV Diagnostic
      • 8.4.4.1. Global DNA Diagnostics Market, by HCV Diagnostic, by Region, 2020-2034 (USD billion)
    • 8.4.5. HIV Diagnostic
      • 8.4.5.1. Global DNA Diagnostics Market, by HIV Diagnostic, by Region, 2020-2034 (USD billion)
    • 8.4.6. HPV Diagnostic
      • 8.4.6.1. Global DNA Diagnostics Market, by HPV Diagnostic, by Region, 2020-2034 (USD billion)
    • 8.4.7. MRSA Diagnostic
      • 8.4.7.1. Global DNA Diagnostics Market, by MRSA Diagnostic, by Region, 2020-2034 (USD billion)
    • 8.4.8. TB Diagnostic
      • 8.4.8.1. Global DNA Diagnostics Market, by TB Diagnostic, by Region, 2020-2034 (USD billion)
    • 8.4.9. Others
      • 8.4.9.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)
  • 8.5. Newborn Genetic Screening
    • 8.5.1. Global DNA Diagnostics Market, by Newborn Genetic Screeningc, by Region, 2020-2034 (USD billion)
  • 8.6. Preimplantation & Reproductive Diagnosis
    • 8.6.1. Global DNA Diagnostics Market, by Preimplantation & Reproductive Diagnosis, by Region, 2020-2034 (USD billion)
  • 8.7. Non-Infectious Diseases DNA Testing
    • 8.7.1. Global DNA Diagnostics Market, by Non-Infectious Diseases DNA Testing, by Region, 2020-2034 (USD billion)
    • 8.7.2. Cardiovascular Diseases
      • 8.7.2.1. Global DNA Diagnostics Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD billion)
    • 8.7.3. CNS & PNS Related
      • 8.7.3.1. Global DNA Diagnostics Market, by CNS & PNS Related, by Region, 2020-2034 (USD billion)
    • 8.7.4. Lung, Kidney, Liver & GT Related
      • 8.7.4.1. Global DNA Diagnostics Market, by Lung, Kidney, Liver & GT Related, by Region, 2020-2034 (USD billion)
    • 8.7.5. Sensory Diseases
      • 8.7.5.1. Global DNA Diagnostics Market, by Sensory Diseases, by Region, 2020-2034 (USD billion)
    • 8.7.6. Skeletal, Connective, Ectodermal & Dermal DNA Testing
      • 8.7.6.1. Global DNA Diagnostics Market, by Skeletal, Connective, Ectodermal & Dermal DNA Testing, by Region, 2020-2034 (USD billion)
  • 8.8. Hematology & Immunology/Identity Diagnostics & Forensics
    • 8.8.1. Global DNA Diagnostics Market, by Hematology & Immunology/Identity Diagnostics & Forensics, by Region, 2020-2034 (USD billion)
  • 8.9. Pharmacogenomics/Drug Metabolism
    • 8.9.1. Global DNA Diagnostics Market, by Pharmacogenomics/Drug Metabolism, by Region, 2020-2034 (USD billion)
  • 8.10. Prenatal DNA Carrier Screening
    • 8.10.1. Global DNA Diagnostics Market, by Prenatal DNA Carrier Screening, by Region, 2020-2034 (USD billion)
  • 8.11. Others
    • 8.11.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)

9. Global DNA Diagnostics Market, by End User

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • 9.3. Diagnostic Laboratories
    • 9.3.1. Global DNA Diagnostics Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD billion)
  • 9.4. Hospitals & clinics
    • 9.4.1. Global DNA Diagnostics Market, by Hospitals & clinics, by Region, 2020-2034 (USD billion)
  • 9.5. Others
    • 9.5.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)

10. Global DNA Diagnostics Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. DNA Diagnostics Market Assessment, By Geography, 2020-2034 (USD billion)
  • 10.3. DNA Diagnostics Market - North America
    • 10.3.1. North America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
    • 10.3.2. North America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
    • 10.3.3. North America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
    • 10.3.4. North America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
    • 10.3.5. North America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.3.7. DNA Diagnostics Market - U.S.
      • 10.3.7.1. U.S.: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.3.7.2. U.S.: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.3.7.3. U.S.: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.3.7.4. U.S.: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.3.7.5. U.S.: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.3.8. DNA Diagnostics Market - Canada
      • 10.3.8.1. Canada: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.3.8.2. Canada: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.3.8.3. Canada: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.3.8.4. Canada: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.3.8.5. Canada: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • 10.4. DNA Diagnostics Market - Europe
    • 10.4.1. Europe: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
    • 10.4.2. Europe: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
    • 10.4.3. Europe: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
    • 10.4.4. Europe: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
    • 10.4.5. Europe: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.4.6. DNA Diagnostics Market - UK
      • 10.4.6.1. UK: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.4.6.2. UK: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.4.6.3. UK: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.4.6.4. UK: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.4.6.5. UK: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.4.7. DNA Diagnostics Market - France
      • 10.4.7.1. France: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.4.7.2. France: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.4.7.3. France: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.4.7.4. France: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.4.7.5. France: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.4.8. DNA Diagnostics Market - Germany
      • 10.4.8.1. Germany: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.4.8.2. Germany: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.4.8.3. Germany: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.4.8.4. Germany: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.4.8.5. Germany: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.4.9. DNA Diagnostics Market - Italy
      • 10.4.9.1. Italy: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.4.9.2. Italy: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.4.9.3. Italy: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.4.9.4. Italy: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.4.9.5. Italy: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.4.10. DNA Diagnostics Market - Spain
      • 10.4.10.1. Spain: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.4.10.2. Spain: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.4.10.3. Spain: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.4.10.4. Spain: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.4.10.5. Spain: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.4.11. DNA Diagnostics Market - Netherlands
      • 10.4.11.1. Netherlands: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.4.11.2. Netherlands: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.4.11.3. Netherlands: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.4.11.4. Netherlands: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.4.11.5. Netherlands: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.4.12. DNA Diagnostics Market - Russia
      • 10.4.12.1. Russia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.4.12.2. Russia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.4.12.3. Russia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.4.12.4. Russia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.4.12.5. Russia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.4.13. DNA Diagnostics Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.4.13.2. Rest of Europe: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.4.13.3. Rest of Europe: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.4.13.4. Rest of Europe: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.4.13.5. Rest of Europe: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • 10.5. DNA Diagnostics Market - Asia Pacific
    • 10.5.1. Asia Pacific: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
    • 10.5.2. Asia Pacific: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
    • 10.5.3. Asia Pacific: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
    • 10.5.4. Asia Pacific: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
    • 10.5.5. Asia Pacific: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.5.6. DNA Diagnostics Market - China
      • 10.5.6.1. China: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.5.6.2. China: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.5.6.3. China: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.5.6.4. China: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.5.6.5. China: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.5.7. DNA Diagnostics Market - India
      • 10.5.7.1. India: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.5.7.2. India: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.5.7.3. India: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.5.7.4. India: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.5.7.5. India: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.5.8. DNA Diagnostics Market - Malaysia
      • 10.5.8.1. Malaysia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.5.8.2. Malaysia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.5.8.3. Malaysia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.5.8.4. Malaysia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.5.8.5. Malaysia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.5.9. DNA Diagnostics Market - Japan
      • 10.5.9.1. Japan: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.5.9.2. Japan: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.5.9.3. Japan: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.5.9.4. Japan: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.5.9.5. Japan: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.5.10. DNA Diagnostics Market - Indonesia
      • 10.5.10.1. Indonesia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.5.10.2. Indonesia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.5.10.3. Indonesia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.5.10.4. Indonesia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.5.10.5. Indonesia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.5.11. DNA Diagnostics Market - South Korea
      • 10.5.11.1. South Korea: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.5.11.2. South Korea: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.5.11.3. South Korea: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.5.11.4. South Korea: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.5.11.5. South Korea: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.5.12. DNA Diagnostics Market - Australia
      • 10.5.12.1. Australia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.5.12.2. Australia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.5.12.3. Australia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.5.12.4. Australia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.5.12.5. Australia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.5.13. DNA Diagnostics Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.5.13.2. Rest of Asia Pacific: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.5.13.3. Rest of Asia Pacific: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.5.13.4. Rest of Asia Pacific: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.5.13.5. Rest of Asia Pacific: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • 10.6. DNA Diagnostics Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
    • 10.6.2. Middle East & Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
    • 10.6.3. Middle East & Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
    • 10.6.4. Middle East & Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
    • 10.6.5. Middle East & Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.6.6. DNA Diagnostics Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.6.6.2. Saudi Arabia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.6.6.3. Saudi Arabia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.6.6.4. Saudi Arabia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.6.6.5. Saudi Arabia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.6.7. DNA Diagnostics Market - UAE
      • 10.6.7.1. UAE: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.6.7.2. UAE: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.6.7.3. UAE: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.6.7.4. UAE: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.6.7.5. UAE: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.6.8. DNA Diagnostics Market - Israel
      • 10.6.8.1. Israel: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.6.8.2. Israel: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.6.8.3. Israel: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.6.8.4. Israel: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.6.8.5. Israel: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.6.9. DNA Diagnostics Market - South Africa
      • 10.6.9.1. South Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.6.9.2. South Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.6.9.3. South Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.6.9.4. South Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.6.9.5. South Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.6.10. DNA Diagnostics Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.6.10.2. Rest of Middle East & Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.6.10.3. Rest of Middle East & Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.6.10.4. Rest of Middle East & Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.6.10.5. Rest of Middle East & Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
  • 10.7. DNA Diagnostics Market - Latin America
    • 10.7.1. Latin America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
    • 10.7.2. Latin America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
    • 10.7.3. Latin America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
    • 10.7.4. Latin America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
    • 10.7.5. Latin America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.7.6. DNA Diagnostics Market - Mexico
      • 10.7.6.1. Mexico: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.7.6.2. Mexico: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.7.6.3. Mexico: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.7.6.4. Mexico: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.7.6.5. Mexico: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.7.7. DNA Diagnostics Market - Brazil
      • 10.7.7.1. Brazil: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.7.7.2. Brazil: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.7.7.3. Brazil: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.7.7.4. Brazil: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.7.7.5. Brazil: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.7.8. DNA Diagnostics Market - Argentina
      • 10.7.8.1. Argentina: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.7.8.2. Argentina: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.7.8.3. Argentina: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.7.8.4. Argentina: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.7.8.5. Argentina: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
    • 10.7.9. DNA Diagnostics Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
      • 10.7.9.2. Rest of Latin America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
      • 10.7.9.3. Rest of Latin America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
      • 10.7.9.4. Rest of Latin America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
      • 10.7.9.5. Rest of Latin America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Abbott
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Agilent Technologies, Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Avalon GloboCare Corp.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Beckman Coulter, Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Bio-Rad Laboratories, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Cepheidc
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. F. Hoffmann-La Roche Ltd
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. GE HealthCare
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Hologic, Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Illumina, Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Siemens Healthcare Private Limited
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Thermo Fisher Scientific Inc.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development